The Texas Department of State Health Services instructed COVID-19 vaccine providers to stop administering the Johnson & Johnson/Janssen vaccine in accordance with the CDC and U.S. FDA’s recommendation. Both federal entities reported that six people developed blood clots six to thirteen days after receiving the vaccine.
Though federal and state health officials stated that blood clots are extremely rare as a side effect, they will continue examining the Johnson & Johnson vaccines to ensure safety.
So far, 500,000 Johnson & Johnson vaccines have been administered in Texas. No blood clot cases have been reported in-state.